ANDA 71388, held by Roxane. Propranolol Hydrochloride.
As of Nov 15, 2026, ANDA 71388 (Propranolol Hydrochloride Intensol), held by Roxane, was first approved by FDA on May 15, 1987, with 11 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 15, 1987 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Propranolol Hydrochloride Intensol80MG/ML ยท concentrate;oral | Propranolol Hydrochloride | Discontinued |
| Aug 1, 2001 | Supplement 15Labeling | Approved | None posted |
| Feb 20, 2001 | Supplement 14Manufacturing | Approved | None posted |
| Feb 20, 2001 | Supplement 13Manufacturing | Approved | None posted |
| Aug 28, 1996 | Supplement 10Manufacturing | Approved | None posted |
| Jan 5, 1994 | Supplement 9Labeling | Approved | None posted |
| May 16, 1991 | Supplement 8Labeling | Approved | None posted |
| Oct 9, 1990 | Supplement 7Labeling | Approved | None posted |
| Mar 9, 1990 | Supplement 6Labeling | Approved | None posted |
| Feb 28, 1990 | Supplement 4Manufacturing | Approved | None posted |
| Jan 16, 1990 | Supplement 5Labeling | Approved | None posted |
| Dec 21, 1988 | Supplement 2Manufacturing | Approved | None posted |
| May 15, 1987 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters